ALSA VENTURES
ALSA Ventures is a London based international life science investor focused on novel therapeutics.
ALSA VENTURES
Social Links:
Founded:
2019-01-01
Status:
Active
Technology used in webpage:
Euro Amazon
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Eternia Investments
Eternia Investments invest in companies that are run by good people who make great products.
Hamilton Venture Capital Ltd
Hamilton Ventures invests in and works with growth stage tech companies. We are about people, ideas and superior execution
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
New Industry Ventures
New Industry Ventures focuses on investments in technology companies specializing in the development of new materials.
Novartis Venture Fund
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Smartech Capital
They invest in technology companies creating innovative products with global ambition
Susten
Susten invest in the leading Energy Transition firms of the future with the knowledge, enthusiasm, and capital.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-09-19 | Axovia Therapeutics | Axovia Therapeutics acquired by ALSA Ventures | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-07-19 | Vantage Biosciences | ALSA Ventures investment in Seed Round - Vantage Biosciences | N/A |
| 2023-04-15 | Jatri | ALSA Ventures investment in Series A - Jatri | N/A |
| 2022-03-02 | Epsilogen | ALSA Ventures investment in Series B - Epsilogen | 30.75 M GBP |
| 2021-03-08 | Promatix | ALSA Ventures investment in Seed Round - Promatix | N/A |
| 2020-02-20 | Montis Biosciences | ALSA Ventures investment in Seed Round - Montis Biosciences | 8.4 M EUR |
More informations about "ALSA Ventures"
ALSA Ventures - Org Chart, Teams, Culture & Jobs - The Org
ALSA Ventures is a life science venture capital investor, focused on early-stage novel therapeutics. They invest across a wide spectrum of therapeutic areas, targeting high unmet …See details»
ALSA Ventures' Leadership Team - Team members and org chart
The leadership team at ALSA Ventures has a history of experience in the pharmaceutical and healthcare industries, with members having served on the board of directors for companies …See details»
ALSA Ventures - Crunchbase Investor Profile
ALSA Ventures invests in seed to early-stage biotechnology, therapeutics, and oncology companies, focusing on Europe and Asia. Learn More. Similar Investments. LifeArc . Find More Contacts for ALSA Ventures. Protected …See details»
Our approach - ALSA Ventures
Our process is heavily reliant on proprietary deal flow. With a rich history of working with hundreds of biotech companies and entrepreneurial teams in past lives, our team is particularly well networked globally to identify and evaluate …See details»
ALSA Ventures - Investments, Portfolio & Company Exits
ALSA Ventures has acquired Axovia Therapeutics on Sep 18, 2023. Unlock for free . Investments. Edit Investments Section. Number of Investments 6. ALSA Ventures has made 6 investments. …See details»
ALSA Ventures - Investment Analysis Team - The Org
The Investment Analysis Team at ALSA Ventures is responsible for conducting thorough evaluations of potential investment opportunities in early-stage therapeutics. This team …See details»
ALSA Ventures - LinkedIn
ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together ...See details»
On Your Mark: ALSA Ventures Lifts Early-Stage …
Oct 3, 2023 Last month, ALSA Ventures announced the acquisition of Axovia Therapeutics Inc, a company working on gene therapies for ciliopathies, and the launch of a new portfolio company, Axovia Therapeutics ...See details»
ALSA latest VC firm to contract Lonza - BioProcess Insider
May 13, 2022 She told BioProcess Insider the deal with ALSA is just the latest in a string of contracts with investment firms for the Swiss contract development and manufacturing …See details»
ALSA Ventures today announced first closing of its European ...
London, UK – ALSA Ventures today announced first closing of its European biotechnology investment fund with commitments of US$59M. Established in 2019 by Alek Safarian, founder …See details»
ALO Ventures Ltd. · 9909 Pine Valley Drive, Suite 416
ALO Ventures Ltd. is a federal corporation in Vaughan incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) Canada. The entity was …See details»
ALSA Ventures announces the acquisition of Axovia Therapeutics …
About ALSA Ventures. ALSA Ventures is an early-stage investor in life sciences. The firm is building a portfolio of companies founded on innovative insights into disease treatment where …See details»
ALO Ventures Ltd. - Company & Director Informations - Canada …
Dec 14, 2017 ALO Ventures Ltd. is a Non-distributing corporation with 50 or fewer shareholders company type , located at 9909 Pine Valley Drive, Suite 416 Vaughan ON L4H 4M1 Canada. It …See details»
ALSA Ventures closes US $59 million European | EurekAlert!
ALSA Ventures is a Europe based biotechnology investor with a focus on novel therapeutics at preclinical POC or early clinical development stage. The firm was established in 2019, by Alek …See details»
Lonza and ALSA Ventures Collaborate to Provide Development …
Alek Safarian, CEO of ALSA Ventures, added: "This framework agreement is a vital piece of the support ecosystem ALSA is developing to assist portfolio companies. Lonza’s comprehensive …See details»
Internships at The ALS Group
The ALS Group has developed and mentored interns for our program since 2017. Primarily the program is staffed with candidates coming from Columbia University’s Enterprise Risk …See details»
The ALS Group's History of Innovation and Expertise
Today, The ALS Group supports clients of all sizes and from all industries by designing custom risk management solutions to fit their needs. Albert Sica, the Firm’s Founder and Managing …See details»
All news - ALSA Ventures
Jun 13, 2022 ALSA Ventures today announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the …See details»
ALSA Ventures Launches European Biotech Clinical Accelerator …
London, UK – ALSA Ventures, a London based European biotech investment firm today announced the launch of Eclipse, a novel clinical development accelerator focused on …See details»